Late recurrence of unilateral graves orbitopathy on the contralateral side.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 11992884)

Published in Am J Ophthalmol on May 01, 2002

Authors

Rachel Kalmann1, Maarten P Mourits

Author Affiliations

1: Orbital Unit, Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands. r.kalmann@oogh.azu.nl

Articles by these authors

Selenium and the course of mild Graves' orbitopathy. N Engl J Med (2011) 3.06

Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid (2008) 2.65

A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. J Clin Endocrinol Metab (2004) 1.87

Prevention of pterygium recurrence by postoperative single-dose beta-irradiation: a prospective randomized clinical double-blind trial. Int J Radiat Oncol Biol Phys (2004) 1.52

Effect of exophthalmometer design on its accuracy. Ophthal Plast Reconstr Surg (2005) 1.48

Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br J Ophthalmol (2006) 1.45

Natural history of spheno-orbital meningiomas. Acta Neurochir (Wien) (2010) 1.38

Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol (2003) 1.29

Re: "Computer-aided analysis of orbital volume: a novel technique". Ophthal Plast Reconstr Surg (2014) 1.07

Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. Eur J Endocrinol (2008) 1.06

Management of porous orbital implants requiring explantation: a clinical and histopathological study. Ophthal Plast Reconstr Surg (2014) 1.06

Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways. Thyroid (2010) 1.01

Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid (2007) 1.01

A new and validated CT-based method for the calculation of orbital soft tissue volumes. Invest Ophthalmol Vis Sci (2008) 1.00

Coronal or swinging eyelid decompression for patients with disfiguring proptosis in Graves' orbitopathy? Comparison of results in one center. Ophthalmology (2005) 0.94

The relationship between the optical density of cataract and its influence on retinal nerve fibre layer thickness measured with spectral domain optical coherence tomography. Acta Ophthalmol (2012) 0.94

Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. Thyroid (2010) 0.90

Effect of smoking on orbital fat and muscle volume in Graves' orbitopathy. Thyroid (2010) 0.88

Do subtypes of graves' orbitopathy exist? Ophthalmology (2010) 0.88

Somatostatin receptor scintigraphy for optic nerve sheath meningiomas. Ophthalmology (2009) 0.85

In-the-bag decentration of a hydrophilic radially asymmetric multifocal intraocular lens secondary to capsule contraction. J Cataract Refract Surg (2013) 0.85

Long-term follow-up of the corneal endothelium after aphakic iris-fixated IOL implantation for bilateral cataract in children. J Cataract Refract Surg (2011) 0.84

Effect of Nd:YAG laser capsulotomy on refraction in multifocal apodized diffractive pseudophakia. J Refract Surg (2012) 0.84

Risk factors for idiopathic orbital inflammation: a case-control study. Br J Ophthalmol (2010) 0.84

Cataract after total body irradiation and bone marrow transplantation: degree of visual impairment. Int J Radiat Oncol Biol Phys (2002) 0.83

Orbital mass as manifestation of Wegener's granulomatosis: an ophthalmologic diagnostic approach. Clin Exp Rheumatol (2011) 0.82

Densities of orbital fat and extraocular muscles in graves orbitopathy patients and controls. Ophthal Plast Reconstr Surg (2011) 0.81

Planning health care for patients with Graves' orbitopathy. Graefes Arch Clin Exp Ophthalmol (2008) 0.81

Long-term follow-up after bilateral Artisan aphakia intraocular lens implantation in two children with Marfan syndrome. J AAPOS (2012) 0.81

Comparison of a hydrophilic and a hydrophobic apodized diffractive multifocal intraocular lens. Int Ophthalmol (2013) 0.80

Age and gender-specific reference values of orbital fat and muscle volumes in Caucasians. Br J Ophthalmol (2009) 0.79

Straylight measurements in contact lens wear. Cornea (2010) 0.79

Intraocular pressure after descemet stripping endothelial keratoplasty (DSEK). Int Ophthalmol (2012) 0.78

Opacification of the Intraocular Lens After Descemet Stripping Endothelial Keratoplasty. Cornea (2015) 0.78

Surgical treatment of sphenoorbital meningiomas. Br J Ophthalmol (2011) 0.78

Rectus extraocular muscle paths and decompression surgery for Graves orbitopathy: mechanism of motility disturbances. Invest Ophthalmol Vis Sci (2002) 0.78

Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study. Br J Ophthalmol (2010) 0.78

Contributions of the capsulorrhexis to straylight. Arch Ophthalmol (2009) 0.78

Autorefraction versus subjective refraction in a radially asymmetric multifocal intraocular lens. Acta Ophthalmol (2014) 0.77

Outcome of inferior and superior rectus recession in Graves' orbitopathy patients. Orbit (2015) 0.76

Ocular adnexal lymphoma classified using the WHO classification: not only histology and stage, but also gender is a predictor of outcome. Orbit (2007) 0.76

What is the aim of immunosuppressive treatment in patients with graves' orbitopathy? Ophthal Plast Reconstr Surg (2014) 0.76

Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease. Orbit (2008) 0.76

Quality of life improves after strabismus surgery in patients with Graves' orbitopathy. Eur J Endocrinol (2014) 0.76

Straylight before and after hyperopic laser in situ keratomileusis or laser-assisted subepithelial keratectomy. J Cataract Refract Surg (2010) 0.75

Re: "Comparison of free tarsoconjunctival grafts and Hughes tarsoconjunctival grafts for lower eyelid reconstruction". Ophthal Plast Reconstr Surg (2011) 0.75

Orbital rhabdomyosarcomas: A review. Saudi J Ophthalmol (2013) 0.75

LASIK flap breakthrough in Nd:YAG laser treatment of epithelial ingrowth. J Refract Surg (2015) 0.75

Optic pit presentation with coexistent orbital cyst. Ophthal Plast Reconstr Surg (2013) 0.75

Evaluation of classification systems for nonspecific idiopathic orbital inflammation. Orbit (2012) 0.75

Unilateral and bilateral medial rectus recession in Graves' Orbitopathy patients. Strabismus (2014) 0.75

Indications for and outcomes of tertiary referrals in refractive surgery. J Refract Surg (2013) 0.75